Cynthia Sung

Years Active: 2017-2020
Publications (10 Years): 5

Bill and Melinda Gates Medical Research Institute

Harvard-MIT (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Bill and Melinda Gates Medical Research Institute

United States

Research Project Manager :: Research Decision Support

Education History

Harvard-MIT

United States

PHD :: Medical Engineering & Medical Physics

Publications

Marc Maliepaard, Anne C Taams, Cynthia Sung, Jalene Poh, Yang Yu
Ethnicity-Specific Drug Safety Data in European Medicines Agency Registration Dossiers, European Public Assessment Reports, and European and Singapore Drug Labels: Lost in Translation? Pharmaceutical medicine 33 (5) (2020)
Gim Gee Teng, Wei-Chuen Tan-Koi, Di Dong, Cynthia Sung
Is HLA-B*58:01 genotyping cost effective in guiding allopurinol use in gout patients with chronic kidney disease? Pharmacogenomics 21 (4) (2020)
Eng Hooi Tan, Zheng Jye Ling, Pei San Ang, Cynthia Sung, Yock Young Dan, Bee Choo Tai
Comparison of laboratory threshold criteria in drug-induced liver injury detection algorithms for use in pharmacovigilance. Pharmacoepidemiology and drug safety 29 (11) (2020)
Sze Ling Chan, Hong Yen Ng, Cynthia Sung, Alexandre Chan, Michael D Winther, Liam R Brunham, Hwee-Lin Wee
Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adults. The pharmacogenomics journal 19 (4) (2018)
Mun Yee Tham, Qing Ye, Pei San Ang, Liza Y Fan, Dukyong Yoon, Rae Woong Park, Zheng Jye Ling, James W Yip, Bee Choo Tai, Stephen J W Evans, Cynthia Sung
Application and optimisation of the Comparison on Extreme Laboratory Tests (CERT) algorithm for detection of adverse drug reactions: Transferability across national boundaries. Pharmacoepidemiology and drug safety 27 (1) (2017)

Cynthia Sung.css-eqlu8i{font-size:small;padding-left:4px;}